The IDF has been acting on the assumption that the Lebanese terrorist group has such systems and has deployed them to the field.
(Nov. 11, 2024 / JNS) The Iranian regime has developed chemical weapons based on opioids, including fentanyl, and could supply them to its regional terrorist proxies including Hamas and Hezbollah, a U.S. expert warns.
Pharmaceutical-based agents, or PBAs, are weaponized drugs with the ability to incapacitate or kill their victims, Hamas expert Matthew Levitt explained in October’s CTC Sentinel, a journal published by the U.S. Military Academy at West Point’s Combating Terrorism Center.
Levitt serves as the director of the Reinhard Program on Counterterrorism and Intelligence at the Washington Institute for Near East Policy and has testified for the U.S. government in numerous terrorism trials since the early 2000s.